{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:18:54Z","timestamp":1758820734911},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":984,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/bjd.12069","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T15:41:03Z","timestamp":1349019663000},"page":"112-119","source":"Crossref","is-referenced-by-count":12,"title":["Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice"],"prefix":"10.1093","volume":"168","author":[{"given":"S.H.","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-S.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.-S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"10.1111\/bjd.12069-BIB1|cit1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.yrtph.2009.04.001","article-title":"Acceptable risk of contact allergy in the general population assessed by CE-DUR - a method to detect and categorize contact allergy epidemics based on patient data","volume":"54","author":"Thyssen","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1111\/bjd.12069-BIB2|cit2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1600-0536.2002.470107.x","article-title":"Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach","volume":"47","author":"Schnuch","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.12069-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0463.2011.02832.x","article-title":"Immunological mechanisms of contact hypersensitivity in mice","volume":"120","author":"Christensen","year":"2012","journal-title":"APMIS"},{"key":"10.1111\/bjd.12069-BIB4|cit4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2567.1997.00360.x","article-title":"Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration","volume":"92","author":"Cumberbatch","year":"1997","journal-title":"Immunology"},{"key":"10.1111\/bjd.12069-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.4049\/jimmunol.150.9.3698","article-title":"An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin","volume":"150","author":"Enk","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB6|cit6","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.4049\/jimmunol.179.10.6830","article-title":"Langerhans cells are required for efficient presentation of topically applied hapten to T cells","volume":"179","author":"Bennett","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.89.4.1398","article-title":"Early molecular events in the induction phase of contact sensitivity","volume":"89","author":"Enk","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12069-BIB8|cit8","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/eji.1830251103","article-title":"Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene","volume":"25","author":"Bour","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1111\/bjd.12069-BIB9|cit9","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.4049\/jimmunol.144.11.4121","article-title":"Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion","volume":"144","author":"Gocinski","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB10|cit10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.jid.5700581","article-title":"Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene","volume":"127","author":"Pickard","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12069-BIB11|cit11","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.0802830","article-title":"CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge","volume":"182","author":"Kish","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.0804108","article-title":"IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses","volume":"183","author":"He","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB13|cit13","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.4049\/jimmunol.177.10.6852","article-title":"CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses","volume":"177","author":"He","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12069-BIB14|cit14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0300-483X(95)03101-K","article-title":"Role of interferon-[gamma] in contact hypersensitivity assessed in interferon-[gamma] receptor-deficient mice","volume":"102","author":"Saulnier","year":"1995","journal-title":"Toxicology"},{"key":"10.1111\/bjd.12069-BIB15|cit15","first-page":"249","article-title":"Diagnosis and management of contact dermatitis","volume":"82","author":"Usatine","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1111\/bjd.12069-BIB16|cit16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0140-6736(92)91757-Y","article-title":"Inhibition of contact allergy reactions by topical FK506","volume":"340","author":"Lauerma","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/bjd.12069-BIB17|cit17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1358\/dot.2002.38.1.677132","article-title":"Topical tacrolimus Protopic","volume":"38","author":"Lazarous","year":"2002","journal-title":"Drugs Today (Barc)"},{"key":"10.1111\/bjd.12069-BIB18|cit18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14656566.5.3.643","article-title":"Pimecrolimus for the treatment of inflammatory skin disease","volume":"5","author":"Wolff","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/bjd.12069-BIB19|cit19","first-page":"123","article-title":"Adverse effects of topical corticosteroid use","volume":"162","author":"Fisher","year":"1995","journal-title":"West J Med"},{"key":"10.1111\/bjd.12069-BIB20|cit20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12069-BIB21|cit21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2003.05735.x","article-title":"Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin","volume":"149","author":"Niwa","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12069-BIB22|cit22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200831030-00001","article-title":"The US FDA \u2018black box\u2019 warning for topical calcineurin inhibitors: an ongoing controversy","volume":"31","author":"Ring","year":"2008","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.12069-BIB23|cit23","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1021\/jm060727j","article-title":"2-Aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor","volume":"49","author":"Das","year":"2006","journal-title":"J Med Chem"},{"key":"10.1111\/bjd.12069-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","article-title":"Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"29","author":"Steinberg","year":"2007","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.12069-BIB25|cit25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.111.187328","article-title":"LCB 03-0110, a novel pan-discoidin domain receptor\/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation","volume":"340","author":"Sun","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/bjd.12069-BIB26|cit26","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2007-07-102061","article-title":"Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets","volume":"110","author":"Rix","year":"2007","journal-title":"Blood"},{"key":"10.1111\/bjd.12069-BIB27|cit27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nchembio.332","article-title":"A chemical and phosphoproteomic characterization of dasatinib action in lung cancer","volume":"6","author":"Li","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1111\/bjd.12069-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cellsig.2010.03.001","article-title":"The Src, Syk, and Tec family kinases: distinct types of molecular switches","volume":"22","author":"Bradshaw","year":"2010","journal-title":"Cell Signal"},{"key":"10.1111\/bjd.12069-BIB29|cit29","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1073\/pnas.0702654104","article-title":"The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib","volume":"104","author":"Hantschel","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.12069-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","article-title":"Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation","volume":"111","author":"Schade","year":"2008","journal-title":"Blood"},{"key":"10.1111\/bjd.12069-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.exphem.2009.09.007","article-title":"Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo","volume":"37","author":"Fraser","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1111\/bjd.12069-BIB32|cit32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)02554-2","article-title":"Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats","volume":"456","author":"Fujii","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bjd.12069-BIB33|cit33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/138945011794751591","article-title":"Dasatinib: an anti-tumour agent via Src inhibition","volume":"12","author":"Gnoni","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1111\/bjd.12069-BIB34|cit34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CMR.0b013e328304974c","article-title":"Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma","volume":"19","author":"Homsi","year":"2009","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12069-BIB35|cit35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(04)00237-7","article-title":"Intravital microscopy: visualizing immunity in context","volume":"21","author":"Sumen","year":"2004","journal-title":"Immunity"},{"key":"10.1111\/bjd.12069-BIB36|cit36","first-page":"91","article-title":"Adhesion molecules in cutaneous inflammation","volume":"189","author":"Barker","year":"1995","journal-title":"Ciba Found Symp"},{"key":"10.1111\/bjd.12069-BIB37|cit37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2007.10.009","article-title":"Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies","volume":"13","author":"Petersen","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1111\/bjd.12069-BIB38|cit38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4161\/derm.15065","article-title":"Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy","volume":"3","author":"Schoepe","year":"2011","journal-title":"Dermatoendocrinology"},{"key":"10.1111\/bjd.12069-BIB39|cit39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2133.1976.tb02279.x","article-title":"Steroid-induced atrophy in an animal and human model","volume":"12","author":"Kirby","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12069-BIB40|cit40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/1523-1747.ep12511301","article-title":"Corticosteroid-induced dermal atrophy in the rat","volume":"69","author":"Young","year":"1977","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12069-BIB41|cit41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","article-title":"Glucocorticoids in T cell apoptosis and function","volume":"63","author":"Herold","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/bjd.12069-BIB42|cit42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.1702904","article-title":"Chemistry and biology of the immunophilins and their immunosuppressive ligands","volume":"251","author":"Schreiber","year":"1991","journal-title":"Science"},{"key":"10.1111\/bjd.12069-BIB43|cit43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00745.x","article-title":"T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance","volume":"228","author":"Salmond","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.12069-BIB44|cit44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/357161a0","article-title":"Profound block in thymocyte development in mice lacking p56lck","volume":"357","author":"Molina","year":"1992","journal-title":"Nature"},{"key":"10.1111\/bjd.12069-BIB45|cit45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0092-8674(92)90309-Z","article-title":"Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn","volume":"70","author":"Appleby","year":"1992","journal-title":"Cell"},{"key":"10.1111\/bjd.12069-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI28034","article-title":"Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy","volume":"117","author":"Tuckermann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12069-BIB47|cit47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1111\/bjd.12069-BIB48|cit48","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1242\/jcs.112.22.4067","article-title":"Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck\/Fgr deficient macrophages","volume":"112","author":"Suen","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1111\/bjd.12069-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1083\/jcb.126.4.1111","article-title":"Beta 2 integrin dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils","volume":"126","author":"Berton","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1111\/bjd.12069-BIB50|cit50","first-page":"297","article-title":"Activation of p58c-fgr and p53\/56lyn in adherent human neutrophils: evidence for a role of divalent cations in regulating neutrophil adhesion and protein tyrosine kinase activities","volume":"45","author":"Yan","year":"1995","journal-title":"J Inflamm"},{"key":"10.1111\/bjd.12069-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.162.2.1120","article-title":"Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck","volume":"162","author":"Mocsai","year":"1999","journal-title":"J Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12069","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12069\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:42:15Z","timestamp":1687740135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/1\/112\/6614379"}},"subtitle":["Suppression of ACD by dasatinib and LCB 03-0110"],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12069","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}